Replies to post #219888 on Biotech Values

[DewDiligence]

ENTX IPO includes warrants, something you don’t often see:

https://finance.yahoo.com/news/entera-bio-ltd-announces-pricing-125356098.html

Entera Bio Ltd…announced today the pricing of its initial public offering of 1,400,000 units, with each unit consisting of one ordinary share and one warrant to purchase 0.5 of an ordinary share, at a combined price of $8.00 per unit. The Company has granted a 30 day overallotment option to the underwriters to purchase up to 210,000 additional ordinary shares and/or 210,000 additional warrants to purchase up to a total of 105,000 ordinary shares.

The units will immediately and automatically separate upon issuance, and the ordinary shares and warrants are expected to begin trading today on The NASDAQ Capital Market under the symbols "ENTX" and "ENTXW", respectively. The warrants will be exercisable immediately at an exercise price of $8.40 per share and will expire five years from the date of issuance, subject to certain exceptions.

…Entera Bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of orally delivered large molecule therapeutics for use in orphan indications and other areas with significant unmet medical need. The Company is initially applying its technology to develop an oral formulation of parathyroid hormone (PTH) for hypoparathyroidism (EB612) and osteoporosis (EB613).